Nasdaq: VRTX
Vertex Pharmaceuticals insiders
The officers, directors and 10% owners of Vertex Pharmaceuticals Incorporated who hold the most stock, valued at the live VRTX price.
$520.66
VRTX today −$15.8M (−2.94%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 20
- Their VRTX stock
- $290M
- Market value
- $132.0B
- Held by ranked insiders
- 0.22%
Insiders by value of VRTX holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Reshma Kewalramani | CEO & President | 86,471 | $45.0M | <0.1% | 2739th |
| 2 | Amit Sachdev | EVP Chief Patient & Ext Af Off | 74,031 | $38.5M | <0.1% | 3089th |
| 3 | Stuart A. Arbuckle | EVP, COO | 63,508 | $33.1M | <0.1% | 3307th |
| 4 | Ourania Tatsis | EVP, Chief Reg. & Quality Off. | 53,572 | $27.9M | <0.1% | 4004th |
| 5 | Bruce I. Sachs | Director | 39,000 | $20.3M | <0.1% | 5124th |
| 6 | Jeffrey M. Leiden | Executive Chairman | 35,237 | $18.3M | <0.1% | 4636th |
| 7 | David Altshuler | EVP, Chief Scientific Officer | 34,477 | $18.0M | <0.1% | 5632nd |
| 8 | Bastiano Sanna | EVP, Cell & Genetic Therapies | 32,038 | $16.7M | <0.1% | 5919th |
| 9 | Charles F. Wagner Jr. | EVP, CO & FO | 31,764 | $16.5M | <0.1% | 5968th |
| 10 | Joy Liu | EVP and Chief Legal Officer | 19,131 | $10.0M | <0.1% | 8814th |
| 11 | Edward Morrow Atkinson III | EVP, Chief Technical Ops. Off. | 18,432 | $9.6M | <0.1% | 9063rd |
| 12 | Carmen Bozic | EVP and CMO | 15,337 | $8.0M | <0.1% | 10392nd |
| 13 | Jonathan Biller | EVP and Chief Legal Officer | 13,659 | $7.1M | <0.1% | 10581st |
| 14 | Kristen Ambrose | SVP & Chief Accounting Officer | 11,624 | $6.1M | <0.1% | 12704th |
| 15 | Duncan McKechnie | EVP, Chief Commercial Officer | 11,001 | $5.7M | <0.1% | 13181st |
| 16 | Alan M. Garber | Director | 7,344 | $3.8M | <0.1% | 12514th |
| 17 | Lloyd Carney | Director | 6,315 | $3.3M | <0.1% | 7553rd |
| 18 | Suketu Upadhyay | Director | 1,558 | $811K | <0.1% | 8206th |
| 19 | Michel Lagarde | Director | 1,132 | $589K | <0.1% | 2176th |
| 20 | Daniel J. Brennan | Director | 795 | $414K | <0.1% | 8006th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Vertex Pharmaceuticals; see each profile for the filing.